NASDAQ:RPTP - Raptor Pharmaceutical Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$9.00 0.00 (0.00 %)
(As of 06/18/2018 04:00 PM ET)
Previous Close$9.00
Today's Range$9.00 - $9.00
52-Week Range$2.94 - $9.05
VolumeN/A
Average Volume1.42 million shs
Market Capitalization$767.76 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Raptor Pharmaceutical (NASDAQ:RPTP)

Raptor Pharmaceutical logoRaptor Pharmaceutical Corp. (Raptor) is a biopharmaceutical company. The Company is focused on developing and commercializing transformative treatments for people affected by diseases. Its product, PROCYSBI (cysteamine bitartrate) is a delayed-release capsules for the management of nephropathic cystinosis in adults and children of over six years. In Europe, PROCYSBI gastro-resistant hard capsules of cysteamine (as mercaptamine bitartrate), is indicated as an orphan medicinal product for the management of nephropathic cystinosis. Its QUINSAIR is a formulation of the antibiotic drug levofloxacin, suitable for inhalation via a nebulizer. It is engaged in developing MP-376 for non-CF bronchiectasis (BE) and nontuberculous mycobacteria (NTM) lung infections. It is also engaged in developing RP105 and RP106 for various diseases.

Receive RPTP News and Ratings via Email

Sign-up to receive the latest news and ratings for RPTP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryBiotechnology
SectorN/A
SymbolNASDAQ:RPTP
CUSIP75382F10
Phone+1-415-4086200

Debt

Debt-to-Equity Ratio1.33
Current Ratio3.57
Quick Ratio3.30

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-43.75%
Return on Equity-77.01%
Return on Assets-15.64%

Miscellaneous

Employees158
Outstanding Shares85,310,000

Raptor Pharmaceutical (NASDAQ:RPTP) Frequently Asked Questions

What is Raptor Pharmaceutical's stock symbol?

Raptor Pharmaceutical trades on the NASDAQ under the ticker symbol "RPTP."

How were Raptor Pharmaceutical's earnings last quarter?

Raptor Pharmaceutical Corp (NASDAQ:RPTP) released its quarterly earnings results on Thursday, August, 4th. The biotechnology company reported ($0.16) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.18) by $0.02. The biotechnology company earned $32.05 million during the quarter, compared to analysts' expectations of $28.52 million. Raptor Pharmaceutical had a negative return on equity of 77.01% and a negative net margin of 43.75%. The company's quarterly revenue was up 37.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.17) earnings per share. View Raptor Pharmaceutical's Earnings History.

Has Raptor Pharmaceutical been receiving favorable news coverage?

Headlines about RPTP stock have been trending somewhat positive on Monday, according to Accern Sentiment. The research firm ranks the sentiment of media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Raptor Pharmaceutical earned a news impact score of 0.01 on Accern's scale. They also assigned news articles about the biotechnology company an impact score of 44.86 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

How do I buy shares of Raptor Pharmaceutical?

Shares of RPTP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Raptor Pharmaceutical's stock price today?

One share of RPTP stock can currently be purchased for approximately $9.00.

How big of a company is Raptor Pharmaceutical?

Raptor Pharmaceutical has a market capitalization of $767.76 million. Raptor Pharmaceutical employs 158 workers across the globe.

How can I contact Raptor Pharmaceutical?

Raptor Pharmaceutical's mailing address is 7 Hamilton Lndg Ste 100, NOVATO, CA 94949-8283, United States. The biotechnology company can be reached via phone at +1-415-4086200.


MarketBeat Community Rating for Raptor Pharmaceutical (RPTP)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  202 (Vote Outperform)
Underperform Votes:  208 (Vote Underperform)
Total Votes:  410
MarketBeat's community ratings are surveys of what our community members think about Raptor Pharmaceutical and other stocks. Vote "Outperform" if you believe RPTP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RPTP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.